No abstract available
MeSH terms
-
Benzamides
-
Biopsy, Needle
-
Dose-Response Relationship, Drug
-
Drug Administration Schedule
-
Follow-Up Studies
-
Humans
-
Imatinib Mesylate
-
Immunohistochemistry
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / diagnosis
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
-
Lichenoid Eruptions / chemically induced*
-
Lichenoid Eruptions / pathology*
-
Male
-
Middle Aged
-
Piperazines / adverse effects*
-
Piperazines / therapeutic use
-
Pyrimidines / adverse effects*
-
Pyrimidines / therapeutic use
-
Risk Assessment
Substances
-
Benzamides
-
Piperazines
-
Pyrimidines
-
Imatinib Mesylate